Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3242
Selected: 0
NCT IDTitle
NCT01603303Preventing Sexual Dysfunction With Aromatase Inhibitors
NCT06522386GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma
NCT01254890Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome
NCT00453661Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities
NCT00556218Meditation and Cognitive Function in Women With Breast Cancer
NCT06088888TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia
NCT00805688Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer
NCT02684227Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer
NCT01812759Fentanyl for Breakthrough Pain in the Emergency Department
NCT03282396Ibrutinib in Treating Participants With Untreated High Risk Smoldering Mantle Cell Lymphoma
NCT02812420Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery
NCT05239403Association Between Gut Microbiome and Dietary Determinants and Vaccine Response
NCT03471260Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
NCT04256941Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study
NCT04129138Patient and Caregiver Attitudes and Beliefs Regarding Prescription of Intranasal Naloxone Spray for Opioid Overdose
NCT02433626Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies
NCT01939730Rituximab + GM-CSF in Patients With Follicular B-Cell Lymphoma
NCT00499343G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients
NCT02606591Houston Independent School District (HISD) Yoga Evaluation
NCT04644952The Rise in Robotic Atypical Segmentectomies
NCT03793140A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations
NCT05056818Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics
NCT04310397Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma
NCT05668949Phase I/II Open Label Study Evaluating the Safety and Efficacy of Combining STAT3 Inhibition (TTI-101) With Anti-PD-1 Therapy (Pembrolizumab) in Patients With Recurrent or Metastatic (RM) Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT00499889Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients
NCT02861417Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
NCT06158139Autologous CAR-T Cells Targeting B7-H3 in PDAC
NCT02389764Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC)
NCT01159236Molecular Triaging of Newly Diagnosed Breast Cancer
NCT01598194Comparison of a Novel 22-gauge Core Biopsy Needle
NCT06536283Opiophobia in Postsurgical Adults With Cancer
NCT00519272A Prospective Study Examining the Barriers to Care for Harris County Cervical Cancer Patients
NCT00918931Obatoclax for Systemic Mastocytosis
NCT00509002Iressa Study in Patients With Salivary Gland Cancer
NCT06450353Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation
NCT01272245Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
NCT00360672Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome
NCT01332630TPI 287 in Breast Cancer Metastatic to the Brain
NCT05025800ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma
NCT04870645Advanced MRI Scan Before and After Radiation Therapy for the Detection of Intracranial Metastasis
NCT00971022Discount Generic Prescription Study
NCT06759701Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
NCT00934128High Flow Oxygen and Bilevel Airway Pressure for Persistent Dyspnea in Patients With Advanced Cancer
NCT05287451Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
NCT00059631Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone
NCT00473551Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies
NCT05041751Myofascial Release or Trigger Point Injections for the Reduction of Post-Mastectomy Pain Syndrome
NCT04555837Alisertib and Pembrolizumab for the Treatment of Patients With Rb-deficient Head and Neck Squamous Cell Cancer
NCT03622775Daratumumab in Treating Participants With Relapsed Multiple Myeloma After Stem Cell Transplant
NCT02093546Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290